pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 2
    CX-717
    Attention Deficit Hyperactivity Disorder (ADHD) EndeavourRx LLC
  • Phase 1
    CX-801
    Head And Neck Squamous Cell Carcinoma (HNSC)$CTMX CytomX Therapeutics, Inc.
  • Preclinical
    CXR-102
    Squamous Non-Small Cell Lung Carcinoma CorriXR Therapeutics Inc
  • Preclinical
← prev
page 80 of 271
next →
Pain89
Neurology1
CYC-126
Treatment Resistant Depression
$CYCN Cyclerion Therapeutics, Inc.
  • Phase 3
    CYCLOSPORINE
    CYCLOSPORINE
    INDICATIONS AND USAGE Kidney, Liver, and Heart Transplant…$AMRX Amneal Pharmaceuticals, Inc.
  • Phase 2
    CYP-001
    Graft Versus Host Disease (GVHD) Cynata Therapeutics Ltd
  • CYSTOGRAFIN DILUTE
    CYSTOGRAFIN DILUTE (DIATRIZOATE MEGLUMINE)
    no indication BRACCO
  • Phase 1
    CYT-1010
    Post-Operative Pain Cytogel Pharma LLC
  • Preclinical
    CYT-102
    Recurrent Glioblastoma Multiforme (GBM) Cytea Bio
  • Phase 2
    CampETEC
    Campylobacter Infections$IMRN Immuron Ltd
  • Marketed
    Camptosar
    Camptosar (irinotecan hydrochloride)
    Colorectal Cancer$PFE PFIZER INC
  • Phase 1
    Campylobacter jejuni [strain CPS81-176] vaccine
    Campylobacter Infections US Army Medical Research & Materiel Command
  • Preclinical
    CanChew RX
    cannabidiol
    Inflammatory Bowel Disease$IXHL Incannex Healthcare Inc.
  • Phase 2
    Cancer Program
    Metastatic Colorectal Cancer Mirror Biologics Inc
  • Preclinical
    CannQuit-O
    Opium (Opioid) Addiction$IXHL Incannex Healthcare Inc.
  • Phase 1
    Cantrixil
    Epithelial Ovarian Cancer Vivesto AB
  • Marketed
    Carbocaine
    Carbocaine (mepivacaine hydrochloride)
    Local Anesthetic Effect$PFE PFIZER INC
  • Phase 2
    Carboxyamidotriazole Orotate
    Pravitinib
    Glioblastoma Multiforme (GBM) Tactical Therapeutics Inc
  • Phase 2
    CardiALLO
    Systolic Heart Failure (HFrEF)$BCDA BioCardia, Inc.
  • Phase 3
    CardiAMP
    CardiAMP
    Myocardial Ischemia$BCDA BioCardia, Inc.
  • Marketed
    Cardizem CD
    Tiazac (diltiazem hydrochloride)
    Chronic Stable Angina Bausch Health US LLC
  • Marketed
    Cardura
    Cardura (doxazosin mesylate)
    Storage Symptoms of Benign Prostatic Hyperplasia$VTRS Viatris Inc
  • Phase 2
    Carfostin
    Non-ischemic Cardiomyopathy Asklepios BioPharmaceutical Inc
  • Phase 2
    CartiLife
    CartiLife
    Articular Cartilage Defect Biosolution Co Ltd
  • Phase 3
    Cartistem
    Cartistem
    Osteoarthritis MediPost Co Ltd
  • Marketed
    Cassipa
    Cassipa ((buprenorphine hydrochloride + naloxone hydrochloride))
    Opium (Opioid) Addiction Teva Pharmaceuticals USA Inc
  • Marketed
    Cefadroxil Teva
    Cefadroxil
    Tonsillitis Teva Pharmaceuticals USA Inc
  • Marketed
    Cefazolin Sodium Hikma
    Cefazolin Sodium
    Septic Arthritis Hikma Pharmaceuticals USA Inc
  • Preclinical
    Cell Therapy for Sickle Cell Disease
    Sickle Cell Disease Safi Biotherapeutics Inc
  • Preclinical
    Cell Therapy for Type 1 Diabetes
    Type 1 Diabetes (Juvenile Diabetes) University of Minnesota